In summary, our study revealed that DHA exerts a therapeutic effect on obesity in an HFD-induced obese mice by inhibiting adipocyte differentiation, and that its mechanism of action may lie in its inhibitory effect on the ROS-producing enzyme NOX4 and abnormal cell-metabolism pathways. This evidence concerns the gene NOX4 and obesity due to melanocortin 4 receptor deficiency.